» Articles » PMID: 20512258

[Serum Markers of Oxidative Stress and Assisted Reproduction Procedures Results in Infertile Patients with Polycystic Ovary Syndrome and Controls]

Overview
Date 2010 Jun 1
PMID 20512258
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the serum levels of five markers of oxidative stress and assisted reproduction (AR) outcomes among infertile patients, with tubal and/or male factor and with polycystic ovary syndrome (PCOS).

Methods: 70 patients were included, 58 with tubal and/or male factor infertility and 12 with PCOS, who underwent controlled ovarian stimulation to perform intracytoplasmic sperm injection (ICSI). A blood sample was collected between the third and fifth day of the menstrual cycle in the month prior to ovarian stimulation. We analyzed the levels of malondialdehyde, hydroperoxides, protein oxidation products, glutathione and vitamin E, by reading the absorbance with a spectrophotometer and by high performance liquid chromatography (HPLC). Data were analyzed statistically by the Student's t-test and Fisher's exact test.

Results: Significant increases in the body mass index, ovarian volume and number of antral follicles were observed in PCOS patients, as well as the use of a lower total dose of follicle stimulating hormone for these patients. There were no differences in the response to ovarian stimulation, in the results of AR or serum levels of malondialdehyde, hydroperoxides, advanced oxidation protein products, glutathione and vitamin E between groups.

Conclusions: The present data did not demonstrate a difference in the levels of serum markers of oxidative stress or in AR results when comparing non-obese infertile patients with PCOS and controls. These data suggest that the results of AR may not be compromised in this specific subgroup of patients with PCOS. However, interpretations of the action of oxidative stress on the results of AR are still not clear and the reproductive implications of oxidative stress need to be better evaluated.

Citing Articles

VEGF-A in COVID-19: a systematic review and meta-analytical approach to its prognostic value.

Bahreiny S, Bastani M, Keyvani H, Mohammadpour Fard R, Aghaei M, Mansouri Z Clin Exp Med. 2025; 25(1):81.

PMID: 40075026 PMC: 11903599. DOI: 10.1007/s10238-025-01583-5.


Association of Free Radical Product and Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.

Bahreiny S, Ahangarpour A, Saki N, Dabbagh M, Ebrahimi R, Mahdizade A Reprod Sci. 2024; 31(6):1486-1495.

PMID: 38212583 DOI: 10.1007/s43032-023-01447-x.


Paraoxonase single nucleotide variants show associations with polycystic ovary syndrome: a meta-analysis.

Kunjantarachot A, Pabalan N, Jarjanazi H, Christofolini D, Montagna E, Barbosa C Reprod Biol Endocrinol. 2020; 18(1):114.

PMID: 33218342 PMC: 7678182. DOI: 10.1186/s12958-020-00665-1.


Relationship between Energy Expenditure Related Factors and Oxidative Stress in Follicular Fluid.

Kazemi A, Ramezanzadeh F, Nasr Esfahani M, Saboor-Yaraghi A, Nejat S, Rahimi-Foroshani A Int J Fertil Steril. 2014; 8(2):175-82.

PMID: 25083183 PMC: 4107692.


Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome.

Kurdoglu Z, Ozkol H, Tuluce Y, Koyuncu I J Endocrinol Invest. 2011; 35(3):317-21.

PMID: 21521935 DOI: 10.3275/7682.